- Home
- FBIO vs EYEN Comparison
FBIO vs EYEN Comparison
Compare FBIO & EYEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- EYEN
- Stock Information
- Founded
- FBIO 2006
- EYEN 2014
- Country
- FBIO United States
- EYEN United States
- Employees
- FBIO N/A
- EYEN N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- EYEN Biotechnology: Pharmaceutical Preparations
- Sector
- FBIO Health Care
- EYEN Health Care
- Exchange
- FBIO Nasdaq
- EYEN Nasdaq
- Market Cap
- FBIO 39.4M
- EYEN 38.2M
- IPO Year
- FBIO N/A
- EYEN 2018
- Fundamental
- Price
- FBIO $1.43
- EYEN $0.10
- Analyst Decision
- FBIO Strong Buy
- EYEN Buy
- Analyst Count
- FBIO 4
- EYEN 3
- Target Price
- FBIO $16.33
- EYEN $12.00
- AVG Volume (30 Days)
- FBIO 605.0K
- EYEN 3.7M
- Earning Date
- FBIO 11-14-2024
- EYEN 11-12-2024
- Dividend Yield
- FBIO N/A
- EYEN N/A
- EPS Growth
- FBIO N/A
- EYEN N/A
- EPS
- FBIO N/A
- EYEN N/A
- Revenue
- FBIO $81,501,000.00
- EYEN $31,832.00
- Revenue This Year
- FBIO N/A
- EYEN $50,943.04
- Revenue Next Year
- FBIO $81.63
- EYEN $397.57
- P/E Ratio
- FBIO N/A
- EYEN N/A
- Revenue Growth
- FBIO 31.51
- EYEN 2557.10
- 52 Week Low
- FBIO $1.36
- EYEN $0.09
- 52 Week High
- FBIO $4.43
- EYEN $2.57
- Technical
- Relative Strength Index (RSI)
- FBIO 31.19
- EYEN 18.14
- Support Level
- FBIO $1.66
- EYEN $0.46
- Resistance Level
- FBIO $1.79
- EYEN $0.51
- Average True Range (ATR)
- FBIO 0.13
- EYEN 0.05
- MACD
- FBIO -0.04
- EYEN -0.03
- Stochastic Oscillator
- FBIO 2.90
- EYEN 3.11
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.